Seller record · Telehealth service

Modern Age

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the weight loss pages, the answers or the terms. 1 more criterion also fails; see the table below.

At a glance

Modern AgeTelehealth service

6/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: Wegovy, Ozempic, Mounjaro, and 4 more
FDA letters: None on file

Visit Modern Age See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A New York City longevity clinic whose clinicians prescribe brand-name GLP-1 medications such as Wegovy, Ozempic, Mounjaro and Rybelsus, or metformin, after a paid lab and clinician assessment, alongside skin, hormone and IV treatments at its Upper East Side clinic.

Operating entity No legal entity name appears in the footer, the terms of use, the privacy policy or the telehealth consent, which name the company only as Modern Age.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Modern Age's weight page; Modern Age's weight loss category page
S2	Prescription gating	PASS	Modern Age's weight page; Modern Age's weight loss category page
S3	Pharmacy identification	PASS	Modern Age's FAQ
S4	Compounding disclosure	PASS	Modern Age's weight loss category page; Modern Age's weight page
S5	Analytical documentation	FAIL	Modern Age's weight loss category page; Modern Age's FAQ; Modern Age's terms and conditions
S6	Business address	PASS	Modern Age's website; Modern Age's privacy page; Modern Age's terms and conditions
S7	Price disclosure	FAIL	Modern Age's weight loss category page; Modern Age's weight page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified clinician reviews the patient's blood panel and health in a one-hour session and decides whether the patient is a candidate for GLP-1 or metformin, with monthly clinician follow-up during the program.Source: Modern Age's weight page; Modern Age's weight loss category page.

S2PASSThe weight loss assessment, a blood panel with a one-hour clinician review, comes first and determines eligibility, and the medication program is offered only to eligible patients after it.Source: Modern Age's weight page; Modern Age's weight loss category page.

S3PASSThe answers name Curexa Pharmacy as the pharmacy partner, with two New Jersey locations at 3007 Ocean Heights Ave., Egg Harbor Township and 236 E Jimmie Leeds Rd, Suite C, Galloway.FDA warning letter 663403 is addressed to Curexa – East, LLC dba Curexa, a pharmacy named here.Source: Modern Age's FAQ.

S4PASSThe weight loss pages say the clinic prescribes the brand-name medications Wegovy, Ozempic, Mounjaro and Rybelsus, described as FDA-approved, or metformin, and offer no compounded GLP-1.Source: Modern Age's weight loss category page; Modern Age's weight page.

S5FAILNo certificate of analysis or lot document is published on the weight loss pages, the answers or the terms.Source: Modern Age's weight loss category page; Modern Age's FAQ; Modern Age's terms and conditions.

S6PASSThe Upper East Side clinic at 1296 3rd Ave, New York, NY 10021, printed in the footer of every page, and 30 Cooper Square, Floor 10, New York, NY 10003 given for written requests in the privacy policy. The terms name New York law.Source: Modern Age's website; Modern Age's privacy page; Modern Age's terms and conditions.

S7FAILNo GLP-1 medication price is printed. The weight loss assessment costs $500 and the program another $500, and the pages say GLP-1 medication is not included and its cost depends on insurance, estimating $900 to $1,600 a month without coverage.Source: Modern Age's weight loss category page; Modern Age's weight page.

S8PASSNo FDA warning letter names Modern Age, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: Wegovy, Ozempic, Mounjaro, Rybelsus, metformin, NAD+ injection, hormone replacement therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

A warning letter to a pharmacy this seller names

FDA warning letter 663403, issued September 2023, to Curexa – East, LLC dba Curexa“During the inspection, the investigators noted serious deficiencies in your practices for producing drug products, which put patients at risk.”

The letter is addressed to the pharmacy, not to Modern Age, and changes no disposition on this record.

Visit Modern Age

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.